• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.39% Nasdaq Down 0.02%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    104.80 Down 1.04(0.98%) 2:07PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:105.84
    Open:106.48
    Bid:105.03 x 100
    Ask:105.40 x 100
    1y Target Est:109.75
    Beta:0.05
    Next Earnings Date: 4-Aug-15LGND Earnings announcement
    Day's Range:102.02 - 106.98
    52wk Range:41.99 - 107.71
    Volume:136,978
    Avg Vol (3m):399,970
    Market Cap:2.06B
    P/E (ttm):208.35
    EPS (ttm):0.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LGND

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 0.98%2.06B
    LLYDown 0.78%90.03B
    MRKUp 1.48%164.91B
    RHHBYUp 0.21%246.19B

    Key Statistics

    Forward P/E (1 yr):31.71
    P/S (ttm):32.94
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.62
    Quarterly EPS Est (Jun-15) :0.40
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):0.85

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback